查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
封面
市场调查报告书
商品编码
1463146

流感治疗药物市场、占有率、规模、趋势、产业分析报告：依流感类型、治疗、分销管道、地区、细分市场、预测，2024-2032年

Influenza Medications Market Share, Size, Trends, Industry Analysis Report, By Influenza Type (Influenza A and Influenza B); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2024- 2032
出版日期: | 出版商: Polaris Market Research | 英文 118 Pages | 商品交期: 最快1-2个工作天内

价格

根据Polaris Market Research的最新研究，预计到2032年，全球流感药物市场规模将达到13.8621亿美元。 该报告提供了对当前市场动态的详细见解，并对未来市场成长进行了分析。

季节性流感流行、传染性呼吸道疾病的流行以及发生流感相关併发症的高风险患者数量的增加是推动市场成长的主要因素。 政府不断采取的举措，例如控制流感传播的疫苗接种计划以及对流感早期诊断和治疗重要性的认识，预计也将进一步推动市场成长。

例如，卫生防护中心2023年9月报告指出，政府疫苗接种计画将于2023年10月开始，政府将继续提供免费季节性流感疫苗接种。

此外，我们正在努力加强流感治疗药物领域的研发活动，针对病毒的不同阶段开发出更有效的抗病毒药物，能够更有效地治疗流感。药物的发展。 例如，根据牛津大学 2023 年 10 月发布的报告，RECOVERY 试验已扩大到研究流感的治疗方法，流感每年导致约 29 万至 65 万人死亡。

由于需要更有效、更安全的抗病毒药物来对抗流感的传播，公司正在推出创新的抗病毒药物，例如下一代抗病毒药物。 这种抗病毒药物具有更高的功效、针对多种流感病毒株的更广谱活性以及更少的副作用，对流感治疗的需求产生了积极影响。

此外，个人化医疗的进步，即根据患者个体特征（例如免疫反应和遗传易感性）量身定制流感治疗，正在进一步增加全球产品需求。 例如，印度科学研究所于 2023 年 7 月进行的一项研究发现，□啶甲酸可以阻止导致包括流感在内的多种疾病的病毒，并且据报导还可能有助于对抗某些病毒性疾病。

流感治疗药物市场报告亮点

由于发病率上升以及人们对正确剂量重要性的认识，甲型流感治疗领域占据了重要占有率

磷酸奥司他韦凭藉高效、抗多种菌株等优势占据大部分市场占有率

线上药局的兴起为患者带来了多种好处，包括便利性和可近性。

由于流感流行和增加研发投资以开发新配方，北美在市场上占据主导地位。

目录

第一章简介

第 2 章执行摘要

第三章研究方法

第四章全球流感药市场洞察

  • 流感治疗市场－通路概况
  • 流感治疗药物市场动态
    • 推动者和机会
      • 流感发生率不断上升，公共卫生意识不断提高
      • 加强研发力道并收紧监管
    • 抑制因素和课题
      • 季节性需求和替代疗法的可用性
  • PESTEL 分析
  • 流感治疗药物市场通路趋势
  • 价值链分析
  • 新冠肺炎 (COVID-19) 影响分析

第五章以流感类型划分的全球市场

  • 主要发现
  • 简介
  • 甲型流感
  • B型流感

第 6 章依处理方式划分的全球市场

  • 主要发现
  • 简介
  • 巴洛沙韦酯
  • 磷酸奥司他韦
  • 其他

第 7 章依通路划分的世界市场

  • 主要发现
  • 简介
  • 医院药房
  • 零售药局
  • 网路药局
  • 其他

第 8 章依地区划分的世界市场

  • 主要发现
  • 简介
    • 2019-2032 年流感治疗市场评估（依地区）
  • 流感药物市场 - 北美
    • 北美：2019-2032 年流感治疗市场（以流感类型）
    • 北美：流感治疗药物市场（依通路），2019-2032 年
    • 北美：流感药物市场，依治疗方法，2019-2032 年
    • 流感治疗药物市场 - 美国
    • 流感药物市场 - 加拿大
  • 流感药物市场 - 欧洲
    • 欧洲：2019-2032 年流感治疗市场（以流感类型）
    • 欧洲：流感治疗市场（依通路），2019-2032 年
    • 欧洲：流感治疗市场（依治疗方式），2019-2032 年
    • 流感药物市场 - 英国
    • 流感药物市场 - 法国
    • 流感药物市场 - 德国
    • 流感药物市场 - 义大利
    • 流感药物市场 - 西班牙
    • 流感药物市场 - 荷兰
    • 流感药物市场 - 俄罗斯
  • 流感治疗市场 - 亚太地区
    • 亚太地区：2019-2032 年流感药物市场（依流感类型）
    • 亚太地区：流感治疗药物市场（依通路），2019-2032 年
    • 亚太地区：流感药物市场（依治疗方法），2019-2032 年
    • 流感治疗药物市场 - 中国
    • 流感药物市场 - 印度
    • 流感药物市场 - 马来西亚
    • 流感治疗药物市场 - 日本
    • 流感治疗药物市场 - 印尼
    • 流感治疗药物市场 - 韩国
  • 流感药物市场 - 中东和非洲
    • 中东和非洲：2019-2032 年流感药物市场（依流感类型）
    • 中东和非洲：流感治疗药物市场（依分销管道），2019-2032 年
    • 中东与非洲：2019-2032 年流感药物市场（依治疗方式）
    • 流感药物市场 - 沙乌地阿拉伯
    • 流感治疗药物市场 - 阿联酋
    • 流感药物市场 - 以色列
    • 流感药物市场 - 南非
  • 流感药物市场 - 拉丁美洲
    • 拉丁美洲：2019-2032 年流感药物市场（以流感类型）
    • 拉丁美洲：流感治疗药物市场，依通路划分，2019-2032 年
    • 拉丁美洲：流感药物市场，依治疗方法，2019-2032 年
    • 流感药物市场 - 墨西哥
    • 流感药物市场 - 巴西
    • 流感药物市场 - 阿根廷

第九章竞争态势

  • 扩张与收购分析
    • 放大
    • 收购
  • 合作/协作/合约/出版物

第十章公司简介

  • AbbVie（US）
  • AstraZeneca（UK）
  • Bayer AG（Germany）
  • Bharat Biotech（India）
  • BioCryst Pharmaceuticals（US）
  • Daiichi Sankyo（Japan）
  • Mylan（US）
  • Novartis AG（Switzerland）
  • Roche Diagnostics（Switzerland）
  • Sanofi SA（France）
  • Seqirus（Australia）
Product Code: PM4800

The global influenza medications market size is expected to reach USD 1,386.21 million by 2032, according to a new study by Polaris Market Research. The report "Influenza Medications Market Share, Size, Trends, Industry Analysis Report, By Influenza Type (Influenza A and Influenza B); By Treatment; By Distribution Channel; By Region; Segment Forecast, 2023 - 2032" gives a detailed insight into current market dynamics and provides analysis on future market growth.

The proliferation of seasonal flu, greater prevalence of contagious respiratory illness, and increasing patient population who are at higher risk of developing flu-related complications, are key factors driving the market growth. Growing number of government initiatives like vaccination programs for controlling the spread of influenza and awareness regarding the importance of early diagnosis and treatment of influenza, are further anticipated to propel market growth.

For instance, according a report by the Centre for Health Protection in September 2023, the Government Vaccination Programme was launched in October 2023 under which the government continued to provide seasonal influenza vaccination for free of cost.

Furthermore, growing research & development activities in the field of influenza medications and growing number of pharmaceutical companies implementing on the development of more effective antiviral drugs that can treat influenza more efficiently through targeting different stages of viral, are further boosting the market's growth. For instance, according to a report by the University of Oxford in October 2023, the RECOVERY trail has been expanded for investigating treatments for influenza that cause deaths of approx. 290,000 to 650,000 people each year.

As the need for effective and safer antiviral drugs to combat the spread of influenza, companies are introducing innovative antiviral drugs like next-generation antiviral drugs which offer enhanced efficacy, broader spectrum of activity against the several influenza strains, and reduced side effects, which is impacting the demand for influenza medications in a positive way.

Additionally, ongoing advances in personalized medicine tailoring to influenza treatment based on individual patient characteristics like immune response and genetic make-up, further escalating the product demand globally. For instance, according to a study done by the Indian Institute of Science in July 2023, it is reported that picolinic acid has the potential to block various disease-causing viruses including influenza and it also help to fight against several viral diseases.

Influenza Medications Market Report Highlights

Influenza A segment accounted for notable share, owing to rising incidences and awareness regarding the importance of proper medications

Oseltamivir phosphate segment held the majority share, that is attributed to its advantages including higher efficiency and effectiveness against several strains

Online pharmacies segment will grow at highest pace, emergence of online pharmacy platforms offering several benefits to patients like convenience and easy accessibility

North America dominated the market, on account of prevalence of influenza and rising investments in R&D activities to develop new formulations

The key market players include Bayer, Roche Diagnostics, Novartis, Sanofi, AstraZeneca, AbbVie, BioCryst Pharmaceuticals, and Mylan

Polaris Market Research has segmented the influenza medications market report based on influenza type, treatment, distribution channel, and region:

Influenza Medications, Influenza Type Outlook (Revenue - USD Million, 2023 - 2032)

  • Influenza A
  • Influenza B

Influenza Medications, Treatment Outlook (Revenue - USD Million, 2023 - 2032)

  • Baloxavir Marboxil
  • Oseltamivir Phosphate
  • Others

Influenza Medications, Distribution Channel Outlook (Revenue - USD Million, 2023 - 2032)

  • Hospital Pharmacies
  • Retail Pharmacies
  • Online Pharmacies
  • Others

Influenza Medications, Regional Outlook (Revenue - USD Million, 2023 - 2032)

  • North America
  • U.S.
  • Canada
  • Europe
  • Germany
  • UK
  • France
  • Italy
  • Spain
  • Russia
  • Netherlands
  • Rest of Europe
  • Asia Pacific
  • China
  • India
  • Japan
  • South Korea
  • Indonesia
  • Malaysia
  • Rest of Asia Pacific
  • Latin America
  • Argentina
  • Brazil
  • Mexico
  • Rest of Latin America
  • Middle East & Africa
  • UAE
  • Saudi Arabia
  • Israel
  • South Africa
  • Rest of Middle East & Africa

Table of Contents

1. Introduction

  • 1.1. Report Description
    • 1.1.1. Objectives of the Study
    • 1.1.2. Market Scope
    • 1.1.3. Assumptions
  • 1.2. Stakeholders

2. Executive Summary

  • 2.1. Market Highlights

3. Research Methodology

  • 3.1. Overview
    • 3.1.1. Data Mining
  • 3.2. Data Sources
    • 3.2.1. Primary Sources
    • 3.2.2. Secondary Sources

4. Global Influenza Medications Market Insights

  • 4.1. Influenza Medications Market - Distribution Channel Snapshot
  • 4.2. Influenza Medications Market Dynamics
    • 4.2.1. Drivers and Opportunities
      • 4.2.1.1. Rising incidences of influenza and increasing awareness about public health
      • 4.2.1.2. Increased R&D efforts and growing regulatory
    • 4.2.2. Restraints and Challenges
      • 4.2.2.1. Seasonal demand and availability of alternative treatments
  • 4.3. Porter's Five Forces Analysis
    • 4.3.1. Bargaining Power of Suppliers (Moderate)
    • 4.3.2. Threats of New Entrants: (Low)
    • 4.3.3. Bargaining Power of Buyers (Moderate)
    • 4.3.4. Threat of Substitute (Moderate)
    • 4.3.5. Rivalry among existing firms (High)
  • 4.4. PESTEL Analysis
  • 4.5. Influenza Medications Market Distribution Channel Trends
  • 4.6. Value Chain Analysis
  • 4.7. COVID-19 Impact Analysis

5. Global Influenza Medications Market, by Influenza Type

  • 5.1. Key Findings
  • 5.2. Introduction
    • 5.2.1. Global Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • 5.3. Influenza A
    • 5.3.1. Global Influenza Medications Market, by Influenza A, by Region, 2019-2032 (USD Million)
  • 5.4. Influenza B
    • 5.4.1. Global Influenza Medications Market, by Influenza B, by Region, 2019-2032 (USD Million)

6. Global Influenza Medications Market, by Treatment

  • 6.1. Key Findings
  • 6.2. Introduction
    • 6.2.1. Global Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 6.3. Baloxavir Marboxil
    • 6.3.1. Global Influenza Medications Market, by Baloxavir Marboxil, by Region, 2019-2032 (USD Million)
  • 6.4. Oseltamivir Phosphate
    • 6.4.1. Global Influenza Medications Market, by Oseltamivir Phosphate, by Region, 2019-2032 (USD Million)
  • 6.5. Others
    • 6.5.1. Global Influenza Medications Market, by Others, by Region, 2019-2032 (USD Million)

7. Global Influenza Medications Market, by Distribution Channel

  • 7.1. Key Findings
  • 7.2. Introduction
    • 7.2.1. Global Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • 7.3. Hospitals Pharmacies
    • 7.3.1. Global Influenza Medications Market, by Hospitals Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.4. Retail Pharmacies
    • 7.4.1. Global Influenza Medications Market, by Retail Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.5. Online Pharmacies
    • 7.5.1. Global Influenza Medications Market, by Online Pharmacies, By Region, 2019-2032 (USD Million)
  • 7.6. Others
    • 7.6.1. Global Influenza Medications Market, by Others, By Region, 2019-2032 (USD Million)

8. Global Influenza Medications Market, by Geography

  • 8.1. Key findings
  • 8.2. Introduction
    • 8.2.1. Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
  • 8.3. Influenza Medications Market - North America
    • 8.3.1. North America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.3.2. North America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.3.3. North America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.4. Influenza Medications Market - U.S.
      • 8.3.4.1. U.S.: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.3.4.2. U.S.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.4.3. U.S.: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.3.5. Influenza Medications Market - Canada
      • 8.3.5.1. Canada: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.3.5.2. Canada.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.3.5.3. Canada: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.4. Influenza Medications Market - Europe
    • 8.4.1. Europe: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.4.2. Europe.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.4.3. Europe: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.4. Influenza Medications Market - UK
      • 8.4.4.1. UK: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.4.2. UK.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.4.3. UK: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.5. Influenza Medications Market - France
      • 8.4.5.1. France: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.5.2. France.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.5.3. France: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.6. Influenza Medications Market - Germany
      • 8.4.6.1. Germany: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.6.2. Germany.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.6.3. Germany: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.7. Influenza Medications Market - Italy
      • 8.4.7.1. Italy: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.7.2. Italy.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.7.3. Italy: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.8. Influenza Medications Market - Spain
      • 8.4.8.1. Spain: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.8.2. Spain.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.8.3. Spain: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.9. Influenza Medications Market - Netherlands
      • 8.4.9.1. Netherlands: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.9.2. Netherlands.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.9.3. Netherlands: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.4.10. Influenza Medications Market - Russia
      • 8.4.10.1. Russia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.4.10.2. Russia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.4.10.3. Russia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.5. Influenza Medications Market - Asia Pacific
    • 8.5.1. Asia Pacific: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.5.2. Asia Pacific.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.5.3. Asia Pacific: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.4. Influenza Medications Market - China
      • 8.5.4.1. China: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.4.2. China.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.4.3. China: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.5. Influenza Medications Market - India
      • 8.5.5.1. India: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.5.2. India.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.5.3. India: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.6. Influenza Medications Market - Malaysia
      • 8.5.6.1. Malaysia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.6.2. Malaysia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.6.3. Malaysia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.7. Influenza Medications Market - Japan
      • 8.5.7.1. Japan: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.7.2. Japan.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.7.3. Japan: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.8. Influenza Medications Market - Indonesia
      • 8.5.8.1. Indonesia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.8.2. Indonesia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.8.3. Indonesia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.5.9. Influenza Medications Market - South Korea
      • 8.5.9.1. South Korea: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.5.9.2. South Korea.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.5.9.3. South Korea: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.6. Influenza Medications Market - Middle East & Africa
    • 8.6.1. Middle East & Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.6.2. Middle East & Africa.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.6.3. Middle East & Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.4. Influenza Medications Market - Saudi Arabia
      • 8.6.4.1. Saudi Arabia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.4.2. Saudi Arabia.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.4.3. Saudi Arabia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.5. Influenza Medications Market - UAE
      • 8.6.5.1. UAE: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.5.2. UAE.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.5.3. UAE: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.6. Influenza Medications Market - Israel
      • 8.6.6.1. Israel: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.6.2. Israel.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.6.3. Israel: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.6.7. Influenza Medications Market - South Africa
      • 8.6.7.1. South Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.6.7.2. South Africa.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.6.7.3. South Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • 8.7. Influenza Medications Market - Latin America
    • 8.7.1. Latin America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
    • 8.7.2. Latin America.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
    • 8.7.3. Latin America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.4. Influenza Medications Market - Mexico
      • 8.7.4.1. Mexico: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.7.4.2. Mexico.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.4.3. Mexico: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.5. Influenza Medications Market - Brazil
      • 8.7.5.1. Brazil: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.7.5.2. Brazil.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.5.3. Brazil: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
    • 8.7.6. Influenza Medications Market - Argentina
      • 8.7.6.1. Argentina: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
      • 8.7.6.2. Argentina.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
      • 8.7.6.3. Argentina: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)

9. Competitive Landscape

  • 9.1. Expansion and Acquisition Analysis
    • 9.1.1. Expansion
    • 9.1.2. Acquisitions
  • 9.2. Partnerships/Collaborations/Agreements/Exhibitions

10. Company Profiles

  • 10.1. AbbVie (US)
    • 10.1.1. Company Overview
    • 10.1.2. Financial Performance
    • 10.1.3. Product Benchmarking
    • 10.1.4. Recent Development
  • 10.2. AstraZeneca (UK)
    • 10.2.1. Company Overview
    • 10.2.2. Financial Performance
    • 10.2.3. Product Benchmarking
    • 10.2.4. Recent Development
  • 10.3. Bayer AG (Germany)
    • 10.3.1. Company Overview
    • 10.3.2. Financial Performance
    • 10.3.3. Product Benchmarking
    • 10.3.4. Recent Development
  • 10.4. Bharat Biotech (India)
    • 10.4.1. Company Overview
    • 10.4.2. Financial Performance
    • 10.4.3. Product Benchmarking
    • 10.4.4. Recent Development
  • 10.5. BioCryst Pharmaceuticals (US)
    • 10.5.1. Company Overview
    • 10.5.2. Financial Performance
    • 10.5.3. Product Benchmarking
    • 10.5.4. Recent Development
  • 10.6. Daiichi Sankyo (Japan)
    • 10.6.1. Company Overview
    • 10.6.2. Financial Performance
    • 10.6.3. Product Benchmarking
    • 10.6.4. Recent Development
  • 10.7. Mylan (US)
    • 10.7.1. Company Overview
    • 10.7.2. Financial Performance
    • 10.7.3. Product Benchmarking
    • 10.7.4. Recent Development
  • 10.8. Novartis AG (Switzerland)
    • 10.8.1. Company Overview
    • 10.8.2. Financial Performance
    • 10.8.3. Product Benchmarking
    • 10.8.4. Recent Development
  • 10.9. Roche Diagnostics (Switzerland)
    • 10.9.1. Company Overview
    • 10.9.2. Financial Performance
    • 10.9.3. Product Benchmarking
    • 10.9.4. Recent Development
  • 10.10. Sanofi SA (France)
    • 10.10.1. Company Overview
    • 10.10.2. Financial Performance
    • 10.10.3. Product Benchmarking
    • 10.10.4. Recent Development
  • 10.11. Seqirus (Australia)
    • 10.11.1. Company Overview
    • 10.11.2. Financial Performance
    • 10.11.3. Product Benchmarking
    • 10.11.4. Recent Development

List of Tables

  • Table 1 Global Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 2 Global Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 3 Global Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 4 Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
  • Table 5 North America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 6 North America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 7 North America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 8 U.S.: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 9 U.S.: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 10 U.S.: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 11 Canada: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 12 Canada: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 13 Canada: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 14 Europe: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 15 Europe: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 16 Europe: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 17 UK: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 18 UK: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 19 UK: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 20 France: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 21 France: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 22 France: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 23 Germany: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 24 Germany: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 25 Germany: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 26 Italy: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 27 Italy: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 28 Italy: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 29 Spain: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 30 Spain: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 31 Spain: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 32 Netherlands: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 33 Netherlands: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 34 Netherlands: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 35 Russia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 36 Russia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 37 Russia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 38 Asia Pacific: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 39 Asia Pacific: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 40 Asia Pacific: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 41 China: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 42 China: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 43 China: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 44 India: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 45 India: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 46 India: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 47 Malaysia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 48 Malaysia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 49 Malaysia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 50 Japan: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 51 Japan: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 52 Japan: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 53 Indonesia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 54 Indonesia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 55 Indonesia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 56 South Korea: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 57 South Korea: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 58 South Korea: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 59 Middle East & Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 60 Middle East & Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 61 Middle East & Africa: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 62 Saudi Arabia: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 63 Saudi Arabia: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 64 Saudi Arabia: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 65 UAE: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 66 UAE: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 67 UAE: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 68 Israel: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 69 Israel: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 70 Israel: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 71 South Africa: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 72 South Africa: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 73 South Africa: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 74 Latin America: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 75 Latin America: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 76 Latin America: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 77 Mexico: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 78 Mexico: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 79 Mexico: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 80 Brazil: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 81 Brazil: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 82 Brazil: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)
  • Table 83 Argentina: Influenza Medications Market, by Influenza Type, 2019-2032 (USD Million)
  • Table 84 Argentina: Influenza Medications Market, by Treatment, 2019-2032 (USD Million)
  • Table 85 Argentina: Influenza Medications Market, by Distribution Channel, 2019-2032 (USD Million)

List of Figures

  • Figure 1. Global Influenza Medications Market, 2019-2032 (USD Million)
  • Figure 2. Integrated Ecosystem
  • Figure 3. Research Methodology: Top-Down & Bottom-Up Approach
  • Figure 4. Market by Geography
  • Figure 5. Porter's Five Forces
  • Figure 6. Market by Treatment
  • Figure 7. Global Influenza Medications Market, by Treatment, 2022 & 2032 (USD Million)
  • Figure 8. Market by Influenza Type
  • Figure 9. Global Influenza Medications Market, by Influenza Type, 2022 & 2032 (USD Million)
  • Figure 10. Market by Distribution Channel
  • Figure 11. Global Influenza Medications Market, by Distribution Channel, 2022 & 2032 (USD Million)
  • Figure 12. Influenza Medications Market Assessment, By Geography, 2019-2032 (USD Million)
  • Figure 13. Strategic Analysis - Influenza Medications Market